Disease Recurrence-The Sword of Damocles in Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis

Katrin Kienzl-Wagner1, Siegfried Waldegger2, Stefan Schneeberger1

  • 1Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Insights

Recurrent focal segmental glomerulosclerosis (FSGS) after kidney transplant is common. B-cell therapies show promise for managing this condition, potentially by targeting a circulating permeability factor.

Area of Science:

  • Nephrology
  • Transplantation Immunology

Background:

  • Primary focal segmental glomerulosclerosis (FSGS) poses a significant risk of recurrence in kidney transplant recipients.
  • Recurrent FSGS affects a substantial proportion of kidney grafts, particularly in patients with prior graft loss due to the disease.

Purpose of the Study:

  • To review current knowledge on permeability factors implicated in FSGS pathogenesis.
  • To discuss management strategies for recurrent FSGS, focusing on B-cell related therapies and graft salvage.

Main Methods:

  • Review of clinical and experimental evidence supporting the role of circulating permeability factors in FSGS.
  • Analysis of treatment options for recurrent FSGS, including plasma exchange and B-cell depletion.

Main Results:

  • Evidence suggests a circulating permeability factor mediates FSGS, though the agent remains unidentified.
  • B-cell depleting antibodies demonstrate effectiveness in managing recurrent FSGS, indicating a potential B-cell link.

Conclusions:

  • Profound B-cell depletion before transplantation may prevent recurrence.
  • Salvaging a kidney allograft affected by recurrent FSGS via transfer to a second recipient is a potential strategy.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
355
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
346
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
596
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
325
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
574
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
359